Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
TSHA
Stock Latest News
Company Announcements
Taysha Gene Therapies’ REVEAL Adult Study: A New Hope for Rett Syndrome?
2d ago
TSHA
Premium
The Fly
Taysha Gene Therapies initiated with a Strong Buy at Raymond James
9d ago
TSHA
Premium
Ratings
Strategic Advantage and Positive Outlook: Taysha Gene Therapies Maintains Buy Rating
12d ago
TSHA
Premium
Company Announcements
Taysha Regains Full Rights to TSHA-102 Program
13d ago
8K
TSHA
Premium
The Fly
Taysha Gene Therapies regains full rights to TSHA-102 program
13d ago
TSHA
Premium
The Fly
Taysha Gene Therapies price target raised to $9 from $8 at BofA
19d ago
TSHA
Premium
Company Announcements
Taysha Gene Therapies Presents Promising TSHA-102 Data
20d ago
8K
TSHA
Premium
The Fly
Taysha Gene Therapies presents new supplemental data analysis from REVEAL study
20d ago
TSHA
Premium
The Fly
Taysha Gene Therapies price target raised to $12 from $7 at Baird
26d ago
TSHA
Premium
The Fly
Neurogene looks ‘deeply undervalued’ after Taysha news, says H.C. Wainwright
27d ago
NGNE
TSHA
Premium
The Fly
Taysha Gene Therapies price target raised to $12 from $7 at Baird
27d ago
TSHA
Premium
The Fly
Berkshire to acquire OxyChem, OpenAI reaches $500B valuation: Morning Buzz
27d ago
BE
RH
Premium
Ratings
Promising Prospects for Taysha Gene Therapies: Buy Rating Backed by Strategic Advancements and Regulatory Endorsements
27d ago
TSHA
Premium
The Fly
Needham ups Taysha target on ‘derisking’ TSHA-102 news
27d ago
TSHA
Premium
The Fly
Taysha Gene Therapies price target raised to $10 from $8 at Needham
27d ago
TSHA
Premium
Ratings
Positive Outlook for Taysha Gene Therapies: Buy Rating Affirmed with FDA Support and Breakthrough Designation
27d ago
TSHA
Premium
Company Announcements
Taysha Gene Therapies Gains FDA Breakthrough Designation
27d ago
8K
TSHA
Premium
The Fly
Taysha Gene Therapies announces FDA BTD to TSHA-102
27d ago
TSHA
Premium
The Fly
Taysha Gene Therapies announces inducement grant under Nasdaq listing rule
2M ago
TSHA
Premium
Company Announcements
Taysha Gene Therapies’ Earnings Call: Progress Amid Challenges
2M ago
TSHA
Premium
Ratings
Positive Outlook for Taysha Gene Therapies: Buy Rating Reinforced by Strong Financial Position and Promising Clinical Progress
3M ago
TSHA
Premium
The Fly
Taysha Gene Therapies price target raised to $14 from $11 at Canaccord
3M ago
TSHA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
